Profile for Soligenix Inc. (SNGX)

$ 1.94   0.03 (+1.57%) Volume: 684.88k 4:00 PM EDT Jul 14, 2020
After Hours:  $ 2.00   0.06 (+3.09%) Volume: 2.74k 7:31 PM EDT Jul 14, 2020
Business Description:
Soligenix Inc focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need.
Address: 29 Emmons Drive, Suite B-10, Princeton, NJ, USA, 08540
Telephone: +1 609 538-8200 Website: https://www.soligenix.com
Facsimile: +1 609 452-6467 Email: [email protected]
Details
CEO: Christopher J. Schaber
Employees: 16 Market Cap: 51.56m
Issue Type: CS
Auditor: EisnerAmper LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 812796
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)